FDA
Health and Fitness

FDA Approves New Drug for Patients with Chronic Liver Disease and Low Blood Platelets and Undergoing a Medical Procedure

Share: Facebook0Twitter0Google+0Linkedin Silver Spring, Maryland—(ENEWSPF)—May 21, 2018 Contact: Sandy Walsh The U.S. Food and Drug Administration today approved Doptelet (avatrombopag) tablets to treat low blood platelet count (thrombocytopenia) in adults with chronic liver disease who READ MORE